Banque Cantonale Vaudoise Heron Therapeutics, Inc. Transaction History

Banque Cantonale Vaudoise

  • $2.43 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022
SELL
$2.66 - $5.37 $5,320 - $10,740
-2,000 Reduced 66.67%
1,000 $4,000
Q1 2021

May 11, 2021
BUY
$14.49 - $20.72 $14,490 - $20,720
1,000 Added 50.0%
3,000 $48,000
Q4 2020

Feb 05, 2021
BUY
$14.61 - $22.14 $20,454 - $30,996
1,400 Added 233.33%
2,000 $42,000
Q3 2020

Oct 30, 2020
BUY
$13.67 - $17.77 $8,202 - $10,662
600 New
600 $8,000

Others Institutions Holding HRTX

# of Institutions
180
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $133M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email